House Bill 7057
116th Congress(2019-2020)
U.C.S. ME/CFS Act
Introduced
Introduced in House on May 28, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
7057
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Understanding COVID-19 Subsets and ME/CFS Act or the U.C.S. ME/CFS Act
This bill requires the National Institutes of Health to support research on myalgic encephalomyelitis/chronic fatigue syndrome among COVID-19 (i.e., coronavirus disease 2019) patients and survivors. This is a serious, chronic, and multisystem disease associated with survivors of viral infections. In addition, the Department of Health and Human Services may carry out a public awareness campaign about post-viral chronic neuroimmune diseases.
May 28, 2020
05/28/2020
Referred to the House Committee on Energy and Commerce.
05/28/2020
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:42:48 PM